Back
NLS Pharmaceutics Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
47
NLSP
NLS Pharmaceutics
Last Price:
$1.64
Seasonality Move:
-13.09%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and NLSP is experiencing slight selling pressure.
NLS Pharmaceutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.67 | Sell |
20-day SMA: | 1.56 | Buy |
50-day SMA: | 1.53 | Buy |
200-day SMA: | 3.41 | Sell |
8-day EMA: | 1.63 | Buy |
20-day EMA: | 1.58 | Buy |
50-day EMA: | 1.63 | Buy |
200-day EMA: | 4.12 | Sell |
NLS Pharmaceutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 57.5 | Buy |
Chaikin Money Flow: | -3842 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.42 - 1.64) | Buy |
Bollinger Bands (100): | (1.48 - 2.1) | Sell |
NLS Pharmaceutics Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NLS Pharmaceutics Stock
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.65 while NLSP 8-day simple moving average is 1.67, which is a Sell signal.
-
The stock price of NLSP is 1.65 while NLS Pharmaceutics 20-day SMA is 1.56, which makes it a Buy.
-
NLS Pharmaceutics 50-day simple moving average is 1.53 while NLSP share price is 1.65, making it a Buy technically.
-
NLSP stock price is 1.65 and NLS Pharmaceutics 200-day simple moving average is 3.41, creating a Sell signal.
NLSP Technical Analysis vs Fundamental Analysis
Sell
47
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy or a Sell?
-
NLS Pharmaceutics stock is rated a SellThe current NLS Pharmaceutics [NLSP] share price is $1.65. The Score for NLSP is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
NLS Pharmaceutics Stock Info
Market Cap:
6.3M
Price in USD:
1.65
Share Volume:
11.4K
NLS Pharmaceutics 52-Week Range
52-Week High:
18.39
52-Week Low:
1.30
Sell
47
NLS Pharmaceutics (NLSP)
is a Sell
NLS Pharmaceutics Share Price Forecast
-
What is the NLS Pharmaceutics stock price today?The NLS Pharmaceutics stock price is 1.65 USD today.
-
Will NLSP stock go up or go down?NLS Pharmaceutics> share price is forecast to RISE/FALL based on technical indicators
-
Is NLS Pharmaceutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NLS Pharmaceutics is overvalued.
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.65 while NLSP 8-day exponential moving average is 1.63, which is a Buy signal.
-
The stock price of NLSP is 1.65 while NLS Pharmaceutics 20-day EMA is 1.58, which makes it a Buy.
-
NLS Pharmaceutics 50-day exponential moving average is 1.63 while NLSP share price is 1.65, making it a Buy technically.
-
NLSP stock price is 1.65 and NLS Pharmaceutics 200-day simple moving average is 4.12, creating a Sell signal.
Technical Analysis of NLS Pharmaceutics
Should I short NLS Pharmaceutics stock?
-
NLSP Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting NLS Pharmaceutics is a Buy
-
NLS Pharmaceutics Relative Strength Index (RSI) is 57.5, which suggest NLS Pharmaceutics is overbought
-
The Bollinger Bands (25) for NLS Pharmaceutics is (1.42 - 1.64), which suggest NLS Pharmaceutics is a Sell
-
The Bollinger Bands (100) for NLS Pharmaceutics is (1.48 - 2.1), which suggest NLS Pharmaceutics is a Sell
* NLS Pharmaceutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.